Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Current Opinion in Pulmonary Medicine
|
July 1, 1996
Recent advances in chemotherapy for lung cancer
R C Lilenbaum
Oncology (Williston Park, N.Y.)
|
May 1, 1994
Multimodality therapy for non-small-cell lung cancer
R C Lilenbaum, M R Green
Clinical Lung Cancer
|
January 21, 2004
Vinorelbine and gemcitabine combinations in advanced non small-cell lung cancer
R C Lilenbaum, R S Herbst
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1993
Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer
R C Lilenbaum, M R Green
Cancer
|
January 15, 1998
Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: a meta-analysis of response, toxicity, and survival
R C Lilenbaum, P Langenberg, K Dickersin
Seminars in Oncology
|
November 24, 1999
Single-agent versus combination chemotherapy in advanced non-small cell lung cancer: a meta-analysis and the Cancer and Leukemia Group B randomized trial
R C Lilenbaum, M List, C Desch
Seminars in Oncology
|
June 1, 1995
A phase I trial of paclitaxel and etoposide for metastatic or recurrent malignancies
M R Green, D A MacManus, R C Lilenbaum
American Journal of Clinical Oncology
|
April 16, 1998
Phase I study of paclitaxel and etoposide for metastatic or recurrent malignancies
R C Lilenbaum, D MacManus, C Engstrom, et al.
American Journal of Hematology
|
January 1, 1995
Copper deficiency-induced anemia and neutropenia secondary to intestinal malabsorption
B A Hayton, H E Broome, R C Lilenbaum
Archives of Pathology & Laboratory Medicine
|
April 13, 2001
Extranodal lymphoplasmacytoid lymphoma (immunocytoma) presenting as small intestinal obstruction
M A Recine, M T Perez, B Cabello-Inchausti, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Current Opinion in Pulmonary Medicine
|
July 1, 1996
Recent advances in chemotherapy for lung cancer
R C Lilenbaum
Oncology (Williston Park, N.Y.)
|
May 1, 1994
Multimodality therapy for non-small-cell lung cancer
R C Lilenbaum, M R Green
Clinical Lung Cancer
|
January 21, 2004
Vinorelbine and gemcitabine combinations in advanced non small-cell lung cancer
R C Lilenbaum, R S Herbst
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1993
Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer
R C Lilenbaum, M R Green
Cancer
|
January 15, 1998
Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: a meta-analysis of response, toxicity, and survival
R C Lilenbaum, P Langenberg, K Dickersin
Seminars in Oncology
|
November 24, 1999
Single-agent versus combination chemotherapy in advanced non-small cell lung cancer: a meta-analysis and the Cancer and Leukemia Group B randomized trial
R C Lilenbaum, M List, C Desch
Seminars in Oncology
|
June 1, 1995
A phase I trial of paclitaxel and etoposide for metastatic or recurrent malignancies
M R Green, D A MacManus, R C Lilenbaum
American Journal of Clinical Oncology
|
April 16, 1998
Phase I study of paclitaxel and etoposide for metastatic or recurrent malignancies
R C Lilenbaum, D MacManus, C Engstrom, et al.
American Journal of Hematology
|
January 1, 1995
Copper deficiency-induced anemia and neutropenia secondary to intestinal malabsorption
B A Hayton, H E Broome, R C Lilenbaum
Archives of Pathology & Laboratory Medicine
|
April 13, 2001
Extranodal lymphoplasmacytoid lymphoma (immunocytoma) presenting as small intestinal obstruction
M A Recine, M T Perez, B Cabello-Inchausti, et al.
Page
of 2